Application of rape receptor gene BnRLP26 in prevention and control of sclerotiniose
By cloning and applying the rapeseed receptor gene BnRLP26, overexpression and CRISPR knockdown transgenic rapeseed was constructed, which solved the problem of prevention and control of rapeseed sclerosis, provided efficient genetic engineering breeding methods, and achieved rapid acquisition of highly resistant rapeseed materials.
Patent Information
- Application Number
- CN202411163165.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-23
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-08-23
AI Technical Summary
The existing technology is difficult to effectively prevent and control sclerosis in rapeseed, and lacks high-resistant varieties. Chemical prevention and control has problems with ecological pollution and drug resistance, and new disease-resistant gene resources are needed.
By cloning and applying the rapeseed receptor gene BnRLP26, overexpression and CRISPR knockdown transgenic rapeseed canola is constructed to enhance or reduce resistance to sclerosis and create rapeseed materials with high or low resistance.
The regulatory effect of the BnRLP26 gene on the resistance to sclerosis of rapeseed bacteria was successfully clarified, and the high-quality antibacterial sclerosis regulation gene resources were provided, which enabled rapid acquisition of high-resistant rapeseed materials through genetic engineering breeding, solving the long breeding cycle and limited resources. The problem.
Smart Images

Figure HDA0005007035160000011 
Figure HDA0005007035160000012
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biotechnology and relates to application of a rapeseed (Brassica napus) receptor gene BnRLP26 in the prevention and control of sclerotinia disease. Background Art
[0002] 1. Plant gene function analysis technology Plant gene function is usually determined and clarified by comparing and analyzing the phenotype or function of abnormal gene expression and normal expression. Abnormal gene expression includes two categories: expression above normal level and expression below normal level. Expression above normal level is mainly over-expression, which is mainly achieved by connecting a strong promoter to drive the expression of the target gene. Expression below normal level is mainly achieved by RNA interference (RNAi), gene knockout and other methods. RNAi is achieved by constructing and transforming a hairpin structure containing the same sequence fragment with an intron or other non-expressed sequence inserted in the opposite direction, resulting in a reduction in the expression of the target gene. Gene knockout is achieved by inserting a long non-plant sequence into the target gene in the plant genome or removing the target gene, resulting in complete or nearly complete inhibition of the expression of the target gene. By constructing gene overexpression plants and / or RNAi plants, gene knockout mutants, and comparing and analyzing the differences in their phenotypes and traits with those of wild-type / normal plants, the regulatory function of the target gene on the trait can be clarified.
[0003] 2. Genetic regulation technology for plant disease resistance Plant disease resistance is the result of plant receptors recognizing pathogen ligands and activating disease resistance signal transduction and a series of defense responses. From a genetic point of view, after receptor-ligand recognition, disease resistance signal transduction is activated, activating immune disease resistance responses. When plants face pathogen invasion, the pattern recognition receptors on the surface of plant cell membranes specifically recognize the conserved molecular patterns of pathogens to activate the first layer of the innate immune system. Pathogen recognition and signal transduction and activation of intracellular disease resistance pathways are crucial for the generation of disease resistance responses. Receptor-like protein (RLP) is one of the two major types of receptors currently known for plant recognition of pathogen molecular patterns. Using RLP genes to create crop germplasm with enhanced disease resistance is expected to be effective, but there are currently very few public reports in this regard.
[0004] 3. Plant Sclerotinia disease prevention and control technology Plant sclerotinia is caused by infection by Sclerotinia sclerotiorum. Sclerotinia sclerotiorum is a necrotrophic pathogenic fungus with a very wide host range. It is a major disease of oil crops and vegetable crops. It causes huge economic losses every year. Due to the lack of highly resistant varieties, chemical control is still an important means. Since some pesticides have problems such as ecological pollution, toxicity to humans and animals, and easy to make pathogens resistant, identifying important anti-sclerotinia regulatory genes and creating and using disease-resistant varieties are crucial for the green prevention and control of sclerotinia.
[0005] 4. Plant disease resistance breeding technology Plant disease resistance breeding technology is mainly divided into two categories: traditional disease resistance breeding and disease resistance breeding through genetic engineering. Traditional disease resistance breeding has natural genetic isolation, which significantly limits the scope of available disease resistance resources. It can only apply disease resistance resources with close genetic relationships, and requires multiple hybridization and backcrossing, etc. Therefore, the breeding cycle is long and requires a lot of manpower and material resources. The genetic engineering breeding method is to introduce exogenous disease resistance regulatory genes into plants through Agrobacterium-mediated methods and other technologies to enable them to obtain disease resistance that they did not originally have. Therefore, the genetic engineering breeding method breaks the limitations of natural genetic isolation, broadens the scope of available disease resistance resources, and has the characteristics of relatively simple and convenient operation, short cultivation cycle, and no need for a lot of manpower and material resources. In addition, varieties with broad-spectrum disease resistance can be created by introducing a broad-spectrum disease resistance regulatory gene, or multiple genes with different disease resistance spectra. Therefore, it has the advantages of being particularly suitable for cultivating broad-spectrum and long-lasting disease-resistant varieties. Summary of the invention
[0006] The present invention aims to provide an application of a rapeseed receptor gene BnRLP26 in the prevention and control of sclerotinia sclerotiorum, which is an application of a rapeseed (Brassica napus) receptor gene BnRLP26 in the prevention and control of sclerotinia sclerotiorum. The rapeseed receptor gene BnRLP26 has a regulating function on sclerotinia sclerotiorum resistance and can be applied to the creation of crop germplasm resistant to Sclerotinia sclerotiorum.
[0007] The application is to obtain rapeseed materials with altered disease resistance by creating transgenic rapeseed, to obtain rapeseed materials with enhanced sclerotinia resistance by creating transgenic rapeseed overexpressing BnRLP26, or to obtain rapeseed materials with weakened sclerotinia resistance by creating BnRLP26-CRISPR transgenic rapeseed.
[0008] The present invention uses the cDNA of the double 11 variety in rapeseed (Brassica napus) as a template, and obtains the rapeseed gene BnRLP26 by PCR cloning, the nucleotide sequence of which is shown in SEQ ID: 1, the open reading frame (ORF) of the gene is 2301bp long, and the encoded protein consists of 766 amino acids, and its sequence is shown in SEQ ID: 2. The BnRLP26 protein contains a transmembrane domain and an LRR (Leucine-rich repeat) domain. The nucleotide sequence cloned by the present invention is consistent with the LOC106383875 nucleotide sequence of the rapeseed variety ZS11 in the NCBI database; the protein sequence cloned by the present invention is the same as XP_022553201.2.
[0009] Prior to the present invention, there was no public report on the function of this gene. This invention, for the first time, clarified the regulatory effect and mechanism of this gene on rapeseed's resistance to Sclerotinia sclerotiorum by constructing overexpression and CRISPR knockout transgenic rapeseed and analyzing its disease resistance. The analysis results of the lesion area of inoculated leaves and the biomass of pathogens showed that compared with wild-type rapeseed plants, overexpression transgenic rapeseed plants were significantly more resistant to Sclerotinia sclerotiorum, while knockout transgenic plants were significantly more susceptible to Sclerotinia sclerotiorum, indicating that BnRLP26 positively regulates rapeseed's resistance to Sclerotinia sclerotiorum.
[0010] Based on the BnRLP26 gene function explained in the present invention, the application purpose of the present invention is to provide the application of the rapeseed BnRLP26 gene in obtaining rapeseed materials with altered disease resistance by creating transgenic rapeseed, including (1) application in obtaining rapeseed materials with increased resistance to sclerotinia by creating transgenic rapeseed overexpressing BnRLP26 (Example 1); and (2) application in obtaining rapeseed materials with reduced resistance to sclerotinia by creating transgenic rapeseed with BnRLP26-CRISPR gene knockout (Example 2).
[0011] The application of the rapeseed BnRLP26 gene in obtaining a rapeseed material with enhanced resistance to sclerotinia sclerotiorum by creating a transgenic rapeseed overexpressing BnRLP26 is specifically achieved by the following steps: (1) Construction and acquisition of BnRLP26 gene overexpression structure: The BnRLP26 gene open reading frame (ORF) was cloned into a plant expression vector so that it was expressed under the drive of a strong promoter; (2) Obtaining Agrobacterium for transformation of BnRLP26 gene overexpression structure: The constructed BnRLP26 gene overexpression structure is transformed into an Agrobacterium strain with strong infection ability to rapeseed by methods such as electric shock; (3) Creation and acquisition of transgenic rapeseed overexpressing BnRLP26: The BnRLP26 gene overexpression structure was introduced into rapeseed by Agrobacterium-mediated method to obtain the transgenic rapeseed overexpressing BnRLP26 gene; (4) Obtaining homozygous transgenic rapeseed lines overexpressing BnRLP26: Using antibiotic resistance and BnRLP26 gene expression as detection indicators, the trait segregation of the offspring of transgenic plants was detected, and homozygous transgenic rapeseed lines overexpressing BnRLP26 whose offspring traits no longer segregated and could be stably inherited were obtained; (5) Screening, identification and acquisition of homozygous transgenic rapeseed lines overexpressing BnRLP26 with enhanced resistance to sclerotinia sclerotinia: Using homozygous transgenic rapeseed lines overexpressing BnRLP26 as materials, the resistance to sclerotinia sclerotinia was detected and analyzed, and transgenic rapeseed with the BnRLP26 gene with enhanced disease resistance was obtained.
[0012] The application of rapeseed BnRLP26 gene in obtaining rapeseed material with reduced resistance to sclerotinia sclerotiorum by creating BnRLP26-CRISPR gene knockout transgenic rapeseed is achieved by the following steps: (1) Construction and acquisition of the CRISPR knockout structure of the BnRLP26 gene: Three 20 bp knockout targets were preset according to the BnRLP26 genome sequence, and the target sequences were cloned into the plant expression vector pBSbdcas9i. The recombinant structure pBSbdcas9i-BnRLP26 was obtained through colony PCR identification and sequencing; (2) Obtaining Agrobacterium transformed with the CRISPR knockout structure of the BnRLP26 gene: The CRISPR knockout structure of the BnRLP26 gene (pBSbdcas9i-BnRLP26) was transformed into an Agrobacterium strain with strong infection ability to rapeseed by electroporation or other methods; (3) Creation and acquisition of rapeseed with CRISPR knockout structure of BnRLP26 gene: The CRISPR knockout structure of BnRLP26 gene was introduced into rapeseed by Agrobacterium-mediated method to obtain rapeseed with CRISPR knockout structure of BnRLP26 gene; (4) Obtaining homozygous rapeseed lines with CRISPR knockout structure of BnRLP26 gene: Screening with antibiotic resistance, detecting the trait segregation of the offspring of transgenic plants, and obtaining homozygous rapeseed lines with CRISPR knockout structure of BnRLP26 gene, in which the offspring traits no longer segregate and can be stably inherited; (5) Screening, identification and acquisition of homozygous rapeseed lines with CRISPR knockout structure of BnRLP26 gene and reduced resistance to sclerotinia sclerotinia: The homozygous rapeseed lines with CRISPR knockout structure of BnRLP26 gene (pBSbdcas9i-BnRLP26) were used as materials to detect and analyze the resistance to sclerotinia sclerotinia, and obtain CRISPR knockout rapeseed with BnRLP26 gene and reduced resistance to sclerotinia sclerotinia.
[0013] Advantages of the present invention: (1) The BnRLP26 gene provided by the present invention is a high-quality anti-bacterial sclerotinia regulatory gene resource, and the disease-resistant material obtained using the gene has the advantages of strong disease resistance. Rapeseed sclerotinia resistance is a quantitative trait resistance controlled by multiple genes. Generally speaking, the degree of regulation of this resistance by a single gene is low. Therefore, rapeseed sclerotinia resistant materials are very scarce worldwide, and there is no highly resistant material. The BnRLP26 gene encodes a receptor-like protein that quickly stimulates an immune response after recognizing the pathogen molecular pattern, and has good resistance stimulation and regulation effects, so it is a high-quality disease-resistant gene resource. Using RLP to create disease-resistant germplasm is an economical, effective and safe way to greenly prevent and control diseases. Therefore, the BnRLP26 gene is a brand-new gene resource suitable for creating and breeding new materials and new varieties of rapeseed resistant to sclerotinia. (2) The period for obtaining disease-resistant materials is short. The methods for obtaining disease-resistant plant materials and varieties mainly include conventional traditional breeding methods and genetic engineering breeding methods using disease-resistant regulatory genes. Traditional breeding methods have the disadvantages of limited range of available disease-resistant resources by natural genetic isolation, long breeding cycle, and requiring a lot of manpower and material resources. Genetic engineering breeding methods have the advantages of wide range of available disease-resistant resources, relatively simple and convenient operation, short breeding cycle, no need for a lot of manpower and material resources, and are particularly suitable for breeding broad-spectrum, durable, and highly disease-resistant varieties. The present invention utilizes the disease-resistant regulatory gene BnRLP26 and adopts genetic engineering methods to create and cultivate rapeseed materials with high resistance to bacterial sclerotinia, which has the characteristics of short cycle and rapid breeding. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] Figure 1It is the gene expression detection of BnRLP26 overexpression plants and the gene editing identification of CRISPR gene knockout plants. Provide evidence of various transgenic rapeseed plants obtained by the present invention, showing the gene expression detection results in BnRLP26 overexpression plants and the editing form of the modified gene in gene knockout plants. Real-time fluorescence quantitative PCR was used to detect the expression level of the gene in BnRLP26 gene overexpression (OE) plants (A), with rapeseed BnACTIN7 as the internal reference gene, and the expression level of ZS11 was set to 1. qRT-PCR analysis was performed three times biologically, each containing three technical replicates, and the expression results were statistically analyzed by Student's t-test using GraphPad Prism, and the data were expressed as mean ± standard deviation. The significance of the difference is indicated by * (**, P<0.01). The results showed that the expression level of BnRLP26 in the two overexpression lines #4 and #13 was significantly increased, 62.4 times and 183.3 times that of the control, respectively (A). Two successful knockout mutant lines #16 and #19, respectively, had a 25 bp deletion at target site 1 of the BnRLP26 gene and a 1 bp insertion at target site 2, both resulting in the inability to normally encode a functional BnRLP26 gene (B), indicating that these plants are true BnRLP26 gene overexpression plants and CRISPR gene knockout plants.
[0015] Figure 2 BnRLP26 positively regulates rapeseed's resistance to Sclerotinia sclerotiorum. Evidence for the antibacterial sclerotinia function of the BnRLP26 gene is provided, showing that BnRLP26 positively regulates rapeseed's resistance to Sclerotinia sclerotiorum. The rapeseed BnRLP26 transgenic plants were inoculated with Sclerotinia sclerotiorum UF-1. The figure shows the results of quantitative statistical analysis of the phenotype, lesion area and mycelial biomass of the overexpression plants (A) and the knockout mutant plants (B) after inoculation. The inoculation experiment was repeated three times. GraphPad Prism was used to perform statistical analysis of the lesion area using Student's t-test, and the data are expressed as mean ± standard deviation. The significance of the difference is indicated by different numbers of * (*, P<0.05; **, P<0.01; ***, P<0.001, ****, P<0.0001). The results showed that the overexpression plants showed a significantly more disease-resistant phenotype than the control (ZS11) plants (A), while the knockout mutant plants were significantly more susceptible to the disease than the control (B). The quantitative analysis of the lesion area showed that the lesion areas of the two strains of the overexpression plants were 109.6 mm 2 and 94.1mm 2 , significantly lower than the control group of 169.2 mm 2, only 65% and 56% of the control; bacterial count determination also showed that the bacterial count in the lesions of the overexpression plants was significantly lower than that of the control plants. The lesion areas of the two knockout mutant lines were 179.3 mm 2 and 178.3mm 2 , significantly higher than the control group of 126.9 mm 2 , which was 1.41 times that of the control; the bacterial load determination also showed that the bacterial load in the lesions of the knockout mutant plants was significantly higher than that of the control plants. These results indicate that BnRLP26 positively regulates rapeseed's resistance to Sclerotinia sclerotiorum. DETAILED DESCRIPTION
[0016] The present invention is further described in conjunction with the accompanying drawings and embodiments.
[0017] Example 1 The present invention cloned a rapeseed gene BnRLP26, and for the first time, by constructing an overexpressed transgenic rapeseed, clarified the function of the gene in conferring rapeseed resistance to sclerotinia. Overexpression of the BnRLP26 gene leads to a significant increase in rapeseed resistance to sclerotinia. Therefore, a new rapeseed material with enhanced resistance to sclerotinia can be created by constructing a homozygous rapeseed line overexpressing the BnRLP26 gene, which can be used for the creation and breeding of sclerotinia-resistant rapeseed varieties, analysis of the function and mechanism of action of the BnRLP26 gene, and the like. The main steps of cloning the BnRLP26 gene, analyzing its function and mechanism, and creating and obtaining new rapeseed materials with enhanced resistance to sclerotinia include:
[0018] 1) Cloning and conservation of the rapeseed BnRLP26 gene The rapeseed BnRLP26 gene provided by the present invention is cloned by the following steps: first, according to the BnRLP26 sequence in the rapeseed genome database, primers BnRLP26-F (5'-atg tcg cta tcg cgt cta cat tcg-3') (sequence as shown in SEQ ID: 3) and BnRLP26-R (5'-tta tcc gca cca acc aaa ata cc-3') (sequence as shown in SEQ ID: 4) are designed. TRIZOL reagent was used to extract total RNA from the leaves of rapeseed variety Zhong Shuang 11, and the high-fidelity enzyme pfu-mediated RT-PCR method was used to amplify and obtain BnRLP26 cDNA. The PCR product was recovered by 1% agarose gel electrophoresis and then purified by gel cutting, connected to the pEASY-Blunt Cloning Vector vector, and transformed into Escherichia coli DH5α by heat shock. The bacteria were cultured overnight in LB medium, and the plasmid was extracted. The PCR method using BnRLP26-F / BnRLP26-R as the primer pair was used to test whether the extracted plasmid contained the BnRLP26 gene. Finally, it was sent to the company for sequencing verification, thereby successfully cloning and obtaining the full-length cDNA sequence of the BnRLP26 gene. The nucleotide sequence of BnRLP26 is shown in SEQ ID: 1, the open reading frame (ORF) of the gene is 2301bp long, and the encoded protein consists of 766 amino acids, and its sequence is shown in SEQ ID: 2. The gene encoding product contains a transmembrane domain and an LRR domain. Through BLAST analysis, it was found that the nucleotide sequence cloned in the present invention was consistent with the nucleotide sequence of LOC106383875 of rapeseed variety ZS11 in the NCBI database, and the protein sequence was the same as XP_022553201.2. Before the present invention, there was no public report on the function of this gene.
[0019] E. coli carrying the pEASY-BnRLP26 vector were transformed and stored in a -80°C refrigerator. The BnRLP26 gene can be subcloned into the target vector at any time by activating the strain, extracting the plasmid, and PCR amplification for transgenic research.
[0020] 2) Construction and acquisition of BnRLP26 gene overexpression structure According to the cloned BnRLP26 sequence of the present invention, primers BnRLP26-F2 (5'-gacgatgataagggcggtacc tcg cta tcg cgt cta cat tcg-3', the italic part is a sequence containing a Kpn I restriction site and consistent with the sequence on the vector pCAMBIA1300) (the sequence is shown in SEQ ID: 5), and BnRLP26-R2 (5'-gtcctaggctacgtaggatcc tta tcc gca cca acc aaa ata cc-3', the italic part is a sequence containing a Bam HI restriction site and consistent with the linearized vector pCAMBIA1300) (the sequence is shown in SEQ ID: 6) were designed. The pEASY-BnRLP26 plasmid obtained in 1) of Example 1 was used as a template, and BnRLP26-F2 / BnRLP26-R2 was used as a primer pair to obtain the target gene by PCR amplification.
[0021] The overexpression vector pCAMBIA1300 plasmid was double-digested with Kpn I and Bam HI, and the amplified target gene was homologously recombined with the pCAMBIA1300 vector after digestion. The reagents used in this experiment were PCR one-step directional cloning kit. The ligation product was transformed into E. coli, screened on kanamycin plates, identified by PCR and sequenced to obtain the BnRLP26 gene overexpression structure pCAMBIA1300-BnRLP26. The overexpression vector pCAMBIA1300 drives the expression of the target gene with the CaMV 35S promoter and carries a FLAG tag to facilitate molecular identification and gene function research.
[0022] 3) Obtaining Agrobacterium transformed with the BnRLP26 gene overexpression construct pCAMBIA1300-BnRLP26 The BnRLP26 gene overexpression structure pCAMBIA1300-BnRLP26 was transformed into an Agrobacterium strain with strong infectivity to rapeseed, such as EHA105, by electroporation and other methods, and the transformants were screened on YEP medium containing kanamycin, and then double-digested with KpnI and Bam HI and identified by PCR to obtain Agrobacterium carrying the BnRLP26 gene overexpression structure pCAMBIA1300-BnRLP26, which was used for the next step of rapeseed genetic transformation.
[0023] 4) Creation and acquisition of BnRLP26 gene overexpression construct pCAMBIA1300-BnRLP26 rapeseed The BnRLP26 gene overexpression construct pCAMBIA1300-BnRLP26 was introduced into rapeseed by Agrobacterium-mediated method to obtain the rapeseed T0 generation transformed with pCAMBIA1300-BnRLP26. The specific operation steps are as follows:
[0024] (i) Seed cleaning and germination 75% ethanol for 30-60s, sterile water once, 1min / time; 0.15% mercuric chloride for 10min, wash twice with sterile water, 1min / time; wash with sterile water for 30min, inoculate on sterile filter paper and dry; inoculate the seeds in culture bottles and culture in the dark at 23℃ for 5-6d.
[0025] (ii) Pre-culture The germinated hypocotyls of rapeseed seedlings were cut into 0.4-0.6 cm segments, inoculated into pre-culture medium, and cultured at 23°C for 2-3 days.
[0026] (iii) Agrobacterium infection and co-cultivation Pick Agrobacterium in the infection solution and prepare OD 600 = 0.2 Agrobacterium resuspension, inoculate the explants in the Agrobacterium suspension for 10 minutes, inoculate the infected explants on sterile filter paper to dry, inoculate on co-culture medium, and culture at 23°C in the dark for 48-72 hours.
[0027] (iv) Degerming (extended screening) The co-cultivated explants were inoculated on sterile culture medium and cultured at 23°C under light for 6 days.
[0028] (v) Screening / differentiation The sterilized explants were inoculated on screening / differentiation medium, 30 explants per dish, cultured at 23°C under light, and the plate was changed every 15 days.
[0029] (vi) Rooting culture The differentiated buds were inoculated into rooting medium and cultured at 23°C under light until roots formed.
[0030] (vii) Detection The CTAB method was used to extract rapeseed genomic DNA, and PCR was used to detect resistance genes.
[0031] (viii) Soil Planting After the kanamycin-resistant seedlings have grown a complete root system, the T0 generation sterile seedlings are incubated with the lid open at 27°C for 2 days, then transplanted into the soil, placed in an incubator for routine management, and finally harvested to obtain T0 seeds.
[0032] 5) Screening, identification and acquisition of homozygous rapeseed lines transformed with the BnRLP26 gene overexpression construct pCAMBIA1300-BnRLP26 Kanamycin resistance and BnRLP26 gene expression were used as detection indicators to detect the segregation of traits in the offspring of transgenic plants. Kanamycin resistance screening was performed on rapeseed seeds on plates containing kanamycin to observe whether they could grow normally into healthy seedlings on kanamycin-resistant plates. Gene expression was detected using methods such as real-time fluorescence quantitative PCR. Obtained homozygous rapeseed lines with BnRLP26 gene overexpression structure pCAMBIA1300-BnRLP26, whose offspring traits no longer separated and could be stably inherited.
[0033] The present invention obtained two rapeseed homozygous lines, OE-line 4 and OE-line 13, which can all grow normally into healthy seedlings on kanamycin resistant plates, and the expression levels of BnRLP26 gene are significantly higher than those of the control plants, which are 62.4 times and 183.3 times of the control, respectively ( Figure 1 A). These plants are true BnRLP26 gene overexpressing plants.
[0034] 6) Disease resistance analysis of homozygous rapeseed lines overexpressing BnRLP26 gene The homozygous rapeseed line overexpressing the BnRLP26 gene obtained in 5) was used as material, and its resistance to rapeseed sclerotinia sclerotiorum was detected and analyzed by inoculating it with Sclerotinia sclerotiorum, thereby clarifying the regulatory role of the BnRLP26 gene on rapeseed sclerotinia sclerotiorum resistance, laying the foundation for using this gene to create and obtain rapeseed resistant to sclerotinia sclerotiorum.
[0035] Activation culture of Sclerotinia sclerotiorum: Select full and uncontaminated sclerotia of Sclerotinia sclerotiorum, cut the sclerotia into two halves with a sterile blade burned by an alcohol lamp, place them with the cut surface facing down on a PDA solid plate, and culture them at 23℃ in the dark for 3 days. Use a 4mm diameter puncher to punch out mycelium blocks 3 to 5mm inward from the edge of the colony, and inoculate them with the mycelium side facing down on a new PDA solid plate. Culture them at 23℃ in the dark for about 36 hours before inoculation.
[0036] Inoculation of Sclerotinia sclerotiorum: Select rape plants with consistent growth for inoculation. Use a 4mm diameter puncher to punch out hyphae blocks 3-5mm inward from the edge of the colony, and inoculate them with the hyphae facing down into the middle of fully developed leaves. Inoculate one hyphae block symmetrically on each half of each leaf, cover with film to keep moisture, and place in a 23℃ greenhouse for cultivation. Take photos and record after an appropriate time (about 24 hours), and analyze the lesion area using ImageJ software.
[0037] The inoculation experiment was repeated three times. The lesion area was statistically analyzed by Student's t-test. The results showed that the BnRLP26 overexpressing plants were significantly more resistant to the disease than the non-transgenic control plants (ZS11). Figure 2A). Quantitative analysis of the lesion area showed that the lesion area of the ZS11 control plant was 169.2 mm 2 The lesion areas of the two strains of overexpression plants were 109.6 mm 2 and 94.1mm 2 , only 65% and 56% of the control ( Figure 2 B).
[0038] These results show that the resistance of BnRLP26 overexpressing plants to sclerotinia is significantly higher than that of non-transgenic control plants. Overexpression of the BnRLP26 gene leads to a significant increase in the resistance of rapeseed to sclerotinia, so BnRLP26 plays a positive regulatory role in the resistance of rapeseed to sclerotinia. The present invention successfully creates a new rapeseed material with high resistance to sclerotinia by constructing BnRLP26-OE rapeseed.
[0039] Example 2 According to the positive regulatory function of the rapeseed gene BnRLP26 on sclerotinia resistance explained in the present invention, a technical system for constructing CRISPR gene knockout transgenic rapeseed of the gene and using genetic engineering technology to create and obtain new rapeseed materials with reduced resistance to sclerotinia resistance has been established. The main steps include:
[0040] (1) Construction and acquisition of CRISPR knockout construct of BnRLP26 gene According to the BnRLP26 genome sequence, three suitable target sites were designed, each gRNA unit contained 20 bp gRNA and a gRNA backbone, and the three gRNA units were combined as a complete knockout functional sequence. Using it as a template, primers BnRLP26-CR-F (5'-cag tgg tct cat gca aac ttc cag tga act cgt ta-3', the italic part is a sequence containing Bsa I or Eco31I restriction sites and consistent with the linearized vector pBSbdcas9i) (sequence as shown in SEQ ID: 7) and BnRLP26-CR-R (5'-cag tgg tct caa aac ttt cac cgg ttt gga agg tt-3', the italic part is a sequence containing Bsa I or Eco31 I restriction sites and consistent with the linearized vector pBSbdcas9i) (sequence as shown in SEQ ID: 8) were used for amplification. The vector pBSbdcas9i was digested with Bsa I or Eco31 I, and recombined with T4 ligase, followed by transformation and kanamycin medium plate screening, picking positive single clones, and PCR identification was performed using pBSbdcas9i identification primers Pbw2+(5'-gca acg ctc tgt cat cgt tac aat-3') (sequence as shown in SEQ ID: 9) and M49452(470C):(5'-cta cgg ttc aag aaa atg taa gct gat-3') (sequence as shown in SEQ ID: 10), and further sequencing identification was performed to obtain the CRISPR knockout structure pBSbdcas9i-BnRLP26.
[0041] (2) Obtaining Agrobacterium transformed with the CRISPR knockout construct of the BnRLP26 gene The BnRLP26 gene CRISPR knockout structure (pBSbdcas9i-BnRLP26) is transformed into an Agrobacterium strain with strong infection ability to rapeseed, such as EHA105, by electroporation and other methods. The transformants are screened on YEP medium containing kanamycin and then identified by PCR to obtain Agrobacterium carrying the BnRLP26 gene CRISPR knockout structure pBSbdcas9i-BnRLP26.
[0042] (3) Creation and acquisition of BnRLP26 gene CRISPR knockout rapeseed The BnRLP26 gene CRISPR knockout structure pBSbdcas9i-BnRLP26 was introduced into rapeseed by Agrobacterium-mediated method to obtain the rapeseed T0 generation transformed with pBSbdcas9i-BnRLP26. The specific operation steps are the same as those described in 4) of Example 1. BnRLP26-CR-F2 (5'-cac ttc ttc ttc act ccc ttc t-3') (sequence as shown in SEQ ID: 11) and BnRLP26-CR-R2 (5'-gca aat ctg gag agg tat gtt c-3') (sequence as shown in SEQ ID: 12) were used to detect whether the transformed seedlings were gene-edited seedlings. Subsequently, the gene-edited seedlings were sequenced near the target site, and finally determined to be mutant plants with successful knockout of the BnRLP26 gene.
[0043] (4) Obtaining homozygous rapeseed lines with CRISPR knockout of BnRLP26 gene The segregation of traits of the offspring of transgenic plants was detected by antibiotic resistance screening. The test was carried out on rapeseed seeds on plates containing Basta resistance to observe whether they can grow normally into healthy seedlings on Basta resistance plates. The homozygous rapeseed lines with the BnRLP26 gene CRISPR knockout structure pBSbdcas9i-BnRLP26, whose offspring traits no longer separated and could be stably inherited, were obtained. All these homozygous rapeseed lines can grow normally into healthy seedlings on Basta resistance plates.
[0044] The present invention obtains a homozygous BnRLP26-CRISPR gene knockout rapeseed line, which can grow normally into healthy seedlings on Basta resistance plates. Sequencing results show that two mutant strains #16 and #19, respectively, have a 25bp deletion at target site 1 of the BnRLP26 gene and a 1bp insertion at target site 2, both of which result in the inability to normally encode a functional BnRLP26 gene ( Figure 1 B), indicating that these plants are true BnRLP26 gene CRISPR knockout plants.
[0045] (5) Screening, identification and acquisition of homozygous rapeseed lines with CRISPR knockout structure of BnRLP26 gene resistant to sclerotinia sclerotinia The homozygous rapeseed line transformed with the BnRLP26 gene CRISPR knockout structure (pBSbdcas9i-BnRLP26) was used as the material to detect and analyze the resistance to sclerotinia. The inoculation method and disease resistance evaluation were the same as those described in 6) of Example 1).
[0046] The results of the Sclerotinia inoculation analysis of the BnRLP26-CRISPR plants constructed by the present invention showed that the BnRLP26-CRISPR gene knockout plants were significantly more susceptible to the disease than the non-transgenic plants (ZS11) control ( Figure 2 B) Quantitative analysis of the lesion area showed that the lesion area of the ZS11 control plant was 126.9 mm 2 The lesion areas of the two knockout mutant strains were 179.3 mm 2 and 178.3mm 2 , which was significantly higher than that of the control plants ( Figure 2 B). It shows that the resistance of BnRLP26-CRISPR plants to Sclerotinia sclerotiorum is significantly lower than that of non-transgenic control plants. The inhibition of BnRLP26 gene expression leads to a significant reduction in the resistance of rapeseed to Sclerotinia sclerotiorum. The present invention successfully creates and obtains a new rapeseed material with reduced resistance to Sclerotinia sclerotiorum by constructing BnRLP26-CRISPR gene knockout rapeseed.
[0047] In summary, the present invention combines Figure 1-Figure 2 The results revealed for the first time the positive regulatory effect of the rapeseed receptor gene BnRLP26 on rapeseed's resistance to Sclerotinia sclerotinia, provided the application approach, application technology and implementation example of BnRLP26 in the creation of Sclerotinia sclerotinia-resistant crop germplasm, and successfully obtained highly resistant Sclerotinia sclerotinia-resistant rapeseed.
Claims
1. An application of a Brassica napus receptor gene BnRLP26 in the prevention and control of sclerotinia sclerotiorum, characterized in that: The nucleotide sequence of the gene BnRLP26 is shown in SEQ ID: 1, and the protein sequence encoded by the gene is shown in SEQ ID:
2.
2. The use according to claim 1, characterized in that: The application is to obtain rapeseed materials with altered disease resistance by creating transgenic rapeseed (Brassica napus).
3. The use according to claim 2, characterized in that: Application in obtaining rapeseed materials with enhanced resistance to sclerotinia sclerotinia by creating transgenic rapeseed overexpressing BnRLP26.
4. The use according to claim 2, characterized in that: Application in obtaining rapeseed materials with weakened resistance to sclerotinia disease by creating BnRLP26-CRISPR gene knockout transgenic rapeseed.
5. The use according to claim 3, characterized in that: The application of rapeseed materials with enhanced resistance to sclerotinia sclerotinia is achieved by the following steps: (1) Construction and acquisition of BnRLP26 gene overexpression structure The open reading frame of the BnRLP26 gene was cloned into a plant expression vector so that it was expressed under the drive of a strong promoter; (2) Obtaining Agrobacterium Transformed with BnRLP26 Gene Overexpression Structure The constructed BnRLP26 gene overexpression structure was transformed into an Agrobacterium strain with strong infection ability to rapeseed by electroporation; (3) Creation and acquisition of transgenic rapeseed overexpressing BnRLP26 The BnRLP26 gene overexpression structure was introduced into rapeseed by Agrobacterium-mediated method to obtain rapeseed transformed with the BnRLP26 gene overexpression structure; (4) Obtaining homozygous transgenic rapeseed lines overexpressing BnRLP26 Using antibiotic resistance and BnRLP26 gene expression as detection indicators, the segregation of traits in the offspring of transgenic plants was detected, and homozygous transgenic rapeseed lines with overexpression of BnRLP26, whose offspring traits no longer segregated and could be stably inherited, were obtained; (5) Screening, identification and acquisition of homozygous transgenic rapeseed lines overexpressing BnRLP26 with enhanced resistance to Sclerotinia sclerotiorum Using the homozygous transgenic rapeseed overexpressing BnRLP26 as material, the resistance to sclerotinia sclerotinia was detected and analyzed, and the transgenic rapeseed with BnRLP26 gene with enhanced disease resistance was obtained.
6. The use according to claim 4, characterized in that: The application of the rape material with reduced resistance to sclerotinia sclerotinia is achieved by the following steps: (1) Construction and acquisition of CRISPR knockout construct of BnRLP26 gene A specific sequence fragment of the BnRLP26 gene was cloned into the CRISPR vector pBSbdcas9i to obtain the CRISPR knockout structure pBSbdcas9i-BnRLP26; (2) Obtaining Agrobacterium transformed with the CRISPR knockout construct of the BnRLP26 gene The BnRLP26 gene CRISPR knockout construct was transformed into an Agrobacterium strain with strong infection ability to rapeseed by electroporation; (3) Creation and acquisition of BnRLP26 gene CRISPR knockout rapeseed The CRISPR knockout structure of the BnRLP26 gene was introduced into rapeseed by Agrobacterium-mediated method to obtain rapeseed transfected with the CRISPR knockout structure of the BnRLP26 gene; (4) Obtaining homozygous rapeseed lines with CRISPR knockout of BnRLP26 gene The characteristics of the offspring of transgenic plants were detected by antibiotic resistance screening, and homozygous rapeseed lines with CRISPR knockout structure of BnRLP26 gene were obtained, in which the offspring characteristics no longer separated and were stably inherited; (5) Screening, identification and acquisition of homozygous rapeseed lines with CRISPR knockout of the BnRLP26 gene that is resistant to bacterial sclerotinia The rapeseed homozygous line with the CRISPR knockout structure of the BnRLP26 gene was used as the material to detect and analyze the resistance to sclerotinia sclerotinia, and the BnRLP26 gene CRISPR knockout rapeseed homozygous line with weakened resistance to sclerotinia sclerotinia was obtained.
Citation Information
Patent Citations
Sclerotinia sclerotiorum small peptide and application thereof
CN114621331A
Application of rape receptor gene BnRLP41 in prevention and control of sclerotiniose
CN118910140A
Plants with improved pathogen resistance
WO2023194291A1
Cited By
Application of rape receptor gene BnRLP41 in prevention and control of sclerotiniose
CN118910140A
Application of Brassica Receptor Gene BnRLP41 in Sclerotinia Disease Prevention and Control
CN118910140B
Brassica napus BnaA02.SABATH1 gene and application of brassica napus BnaA02.SABATH1 gene in prevention and control of sclerotiniose of cruciferous crops
CN122081387A
Brassica napus bnaa02.sabath1 gene and application thereof in prevention and control of sclerotinia stem rot of cruciferous crops
CN122081387B
